Goldman Sachs’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-806,480
| Closed | -$145M | – | 4464 |
|
|
2017
Q3 | $145M | Buy |
806,480
+411,200
| +104% | +$73.9M | 0.04% | 506 |
|
|
2017
Q2 | $41M | Buy |
395,280
+181,336
| +85% | +$18.8M | 0.01% | 1135 |
|
|
2017
Q1 | $16.8M | Buy |
213,944
+127,358
| +147% | +$10M | ﹤0.01% | 1601 |
|
|
2016
Q4 | $3.88M | Buy |
86,586
+718
| +0.8% | +$32.2K | ﹤0.01% | 2326 |
|
|
2016
Q3 | $4.8M | Buy |
85,868
+43,806
| +104% | +$2.45M | ﹤0.01% | 2260 |
|
|
2016
Q2 | $2.1M | Sell |
42,062
-30,621
| -42% | -$1.53M | ﹤0.01% | 2580 |
|
|
2016
Q1 | $3.34M | Buy |
72,683
+29,720
| +69% | +$1.36M | ﹤0.01% | 2274 |
|
|
2015
Q4 | $2.65M | Buy |
42,963
+9,180
| +27% | +$566K | ﹤0.01% | 2381 |
|
|
2015
Q3 | $1.88M | Sell |
33,783
-13,943
| -29% | -$776K | ﹤0.01% | 2579 |
|
|
2015
Q2 | $2.91M | Buy |
47,726
+40,490
| +560% | +$2.47M | ﹤0.01% | 2373 |
|
|
2015
Q1 | $417K | Buy |
+7,236
| New | +$417K | ﹤0.01% | 3435 |
|